Trevor Feinstein

SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

Hossein Borghaei, Filippo de Marinis, Daphne W. Dumoulin et al. · Annals of Oncology · 2023 · 93 citations · Full text

Medicine, Oncology, Pharmacology +13

Circulating tumor DNA (ctDNA) for informing adjuvant chemotherapy (ACT) in stage II/III colorectal cancer (CRC): Interim analysis of BESPOKE CRC study.

Pashtoon Murtaza Kasi, Vasily N. Aushev, Joe Ensor et al. · Journal of Clinical Oncology · 2024 · 66 citations

Medicine, Molecular Medicine, Oncology +17

Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer

Athanassios Argiris, Steve Lee, Trevor Feinstein et al. · Oral Oncology · 2011 · 49 citations · Full text

Medicine, Oncology, Molecular Oncology +8

Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy‐induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials

Renata Ferrarotto, Ian C. Anderson, Balazs Medgyasszay et al. · Cancer Medicine · 2021 · 49 citations · Full text

Medicine, Hematology, Oncology +17

Prognostic factors in patients with high‐risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy

Trevor Feinstein, Stephen Y. Lai, Diana Lenzner et al. · Head & Neck · 2011 · 45 citations · Full text

Medicine, Oncology, Surgery +12